Intuitive Surgical Inc (NASDAQ:ISRG) reported Q4 financial results with a 17% year-over-year revenue increase to $1.93 billion, surpassing the $1.87 billion estimate. Earnings per share were $1.60, beating the $1.48 estimate. The company saw a 21% growth in da Vinci procedures and placed 415 da Vinci systems, a 12% increase from the previous year. The installed base grew to 8,606, up 14%. Despite Covid-19 impacts in China, there were no significant disruptions in Q4 2023. The company ended the quarter with $7.34 billion in cash and investments. Analysts generally rate ISRG as a Buy, with Adam Maeder from Piper Sandler being highly optimistic. Over the past three months, ISRG stock rose 47.76%, reflecting positive investor sentiment.